In Genroku 3 (1690), Toyama clan 2nd Lord Masatoshi Maeda preached " Circulate our medicine widely even in remote places in Japan where medical service is not available, by use first, pay later basis " . Pharmaceutical i n d u s t r y o f T o y a m a o b t a i n e d c l i e n t ' s credibility and trust, obeying the Lord's phrase above and responding to the client's request. Based on proper handling of medicine and building a relationship of trust with clients, pharmaceutical industry of Toyama has grown. The production amount of medicines is 732.5 billion yen and the production amount per capita is the largest in Japan. The pharmaceutical industry made up 16.8 % of the value of shipments of manufactured goods in Toyama prefecture. Ten thousand p e o p l e a r e w o r k i n g i n p h a r m a c e u t i c a l industries in Toyama.Toyama prefecture ranks second in Happiness ranking reported by Hosei University. The housing and income situation in Toyama prefecture is fairly good. Toyama prefecture ranks third in the livability ranking. Pharmaceutical industry has deeply contributed to the people who live in Toyama. In this lecture I will explain the historical background of the Toyama pharmaceutical industry. I would also like to mention the current state of Koukandou that was founded 143 years before and also is succeeding to Hangontan factory established in Bunka 13 (1816), and has played an important role in the history of Pharmaceutical industry in Toyama.
EL-1
Use first, pay later! The history and current situation of pharmaceutical industry in Toyama ○ Yasuhiko Shioi KOKANDO Co., Ltd 〔Educational Lecture 1〕 I will describes current laws, regulations, guidelines and principles pertaining to laboratory animals used for research, teaching and testing in some countries of Korea. The importance of laboratory animal science is getting more cognized in our countries. The biomedical scientists have contributed to establish the national legislation system in our countries by the reflection of the public concern of animal welfare. In Korea, the scientists are acting in laboratory animal science and then the amendment of Laws, Regulations and Guidelines for laboratory animals follows with the scientists' advice. The most recent improvement of legislation system in laboratory animals depends on the advancement of biomedical science, the internationalization of our country and the public interest in animal welfare. In the recent revision of laws, regulation and guidelines in Asia, the Three 3Rs are emphasized in animal protection law revised in 2007. In Korea, there are two kinds of acts about animal experimentation. One is the Animal Protection Act (APA) which is managed by the Ministry of Agriculture, Food and Rural Affairs (MAFRA); and the other is the Laboratory Animal Act (LAA) which is managed by the Ministry of Food and Drug Safety (MFDS). The Acts mandate that animal facilities must establish an Institutional Animal Care and Use Committee (IACUC). Registration in government is the duty of both the experimental and production animal facilities. The workers must be certified for training from government. In addition, the animal research protocols must be approved by the IACUC. The LAA started to designate excellent animal testing facilities with the introduction of certification schemes to entice the ethical and scientific animal experiments. Each experimental animal facility creates its own guidelines, based on the APA and LAA, to perform the ethical operation and maintenance of the animal facility. In this chapter, the ethical use of experimental animals, based on the APA and the, LAA is described.
